All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
During the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the ALL Hub spoke with Giovanna Lucchini, Great Ormond Street Hospital, London, UK. We asked, How does graft-versus-host disease (GvHD) affect outcomes for pediatric patients undergoing allogeneic stem cell transplantation (allo-SCT) for acute lymphoblastic leukemia (ALL)?
How does GvHD affect outcomes for pediatric patients undergoing allo-SCT for ALL?
Lucchini begins by describing how background disorders impact GvHD in patients post transplant. Lucchini then discusses the concept of engineering GvHD that is 'enough, but not too much' and highlights the need for more strategies to support patients and control GvHD.
Validity of the Minnesota aGvHD risk score in predicting survival and response to therapy
At the 48th Annual Meeting of the European Society for Bone and Marrow Transplantation (EBMT), Maria Teresa Lupo-Stanghellini presented a single-center study...
Editorial theme | Consensus statements for pediatric GvHD: Recommendations from the EBMT Transplant Complications Working Party
Graft-versus-host disease (GvHD) remains a considerable contributor to mortality and morbidity in patients receiving...
Subscribe to get the best content related to GvHD delivered to your inbox